A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery
Completed
Conditions studied: Intraocular Inflammation
In brief
Patients are routinely given steroid eye drops following cataract surgery. This study will compare 2 approved drops:Loteprednol Etabonate versus Prednisolone Acetate Eye drops used following cataract surgery. Patients will be randomly assigned to one drop or the other, and evaluated for inflammation and intraocular pressure as part of the comparison. The study Doctor will be masked as to which drop the patient receives to avoid bias.
Key facts
- Study ID
- NCT01384266
- Run by
- Associated Eye Care, Minnesota
- People needed
- 90
- Starts
- 2010-05-01
- Expected to finish
- 2011-11-01
- Last updated by the study team
- 2017-06-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Subjects age 18 and older undergoing routine cataract surgery.
You may not qualify if…
- Subjects being treated for elevated intraocular pressure, retinopathy, maculopathy, cornea or vitreous opacities that would interfere with visual acuity.
- Subjects with diabetes, pseudoexfoliation, uveitis, corneal endothelial disease, or active Herpes Simplex Virus(HSV) or Herpes Zoster Virus(HZV) Pupil Stretch and/or Limbal Relaxing Incision(LRIs) will be allowed.
- Subjects with previous ocular trauma or intraocular surgery
- Subjects with sensitivities to steroids.
- Women who are not post-menopausal or are of child bearing potential will be excluded.
- Intraoperative complications during surgery including posterior capsule rupture and vitreous loss
- Subjects with best visual potential in the fellow eye worse than 20/60
- Subjects who are expected to require concurrent ocular or systemic therapy with non-steroidal anti-inflammatory drugs (NSAIDS) mast cell stabilizers, antihistamines, or decongestants within 2 days prior to or during the 21 days following surgery. (Intraoperative NSAIDS for mydriasis are permitted.) 325 mg Aspirin is permitted.
- Subjects who are expected to require concurrent ocular or systemic corticosteroids, immunosuppressants (including Restasis) within 14 days prior to or 21 days following surgery
Where it is running
- Cincinnati Eye Institute — Edgewood, Kentucky, United States
- Associated Eye Care — Stillwater, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.